Nongenetic screening of ovarian malignancies (Q34477342)

2 August 2017

1 reference

title

Nongenetic screening of ovarian malignancies (English)

1 reference

2 August 2017

Schwartz PE

1

1 reference

2 August 2017

publication date

1 December 2001

1 reference

Obstetrics and Gynecology Clinics of North America

2 August 2017

published in

1 reference

2 August 2017

volume

28

1 reference

2 August 2017

issue

4

1 reference

2 August 2017

page(s)

637-51, vii

1 reference

A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970226-6

7 January 2021

Screening for early familial ovarian cancer with transvaginal ultrasonography and colour blood flow imaging.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970226-6

7 January 2021

Transabdominal ultrasound screening for early ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970226-6

7 January 2021

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970226-6

1 reference

7 January 2021

"Incessant ovulation" and ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970226-6

7 January 2021

Familial ovarian cancer. Update and clinical applications

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970226-6

7 January 2021

Extraovarian peritoneal serous papillary carcinoma. A clinicopathologic study of 31 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970226-6

7 January 2021

Can fenretinide protect women against ovarian cancer?

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970226-6

7 January 2021

Ovarian cancer screening in asymptomatic postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970226-6

7 January 2021

Early detection of familial ovarian cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970226-6

7 January 2021

Incessant ovulation--a factor in ovarian neoplasia?

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970226-6

7 January 2021

Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970226-6

7 January 2021

Sequence analysis of BRCA1 and BRCA2: correlation of mutations with family history and ovarian cancer risk

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970226-6

7 January 2021

Prospective study of talc use and ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970226-6

7 January 2021

Cancer statistics, 2000.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970226-6

7 January 2021

Tubal ligation, hysterectomy, and risk of ovarian cancer. A prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970226-6

7 January 2021

An epidemiologic study of epithelial carcinoma of the ovary

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970226-6

7 January 2021

BRCA1 and BRCA2--breast cancer susceptibility genes

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970226-6

7 January 2021

Growth retardation and tumour inhibition by BRCA1.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970226-6

7 January 2021

Prevalence screening for ovarian cancer in postmenopausal women by CA 125 measurement and ultrasonography

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970226-6

7 January 2021

Risk of diagnosis of ovarian cancer after raised serum CA 125 concentration: a prospective cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970226-6

7 January 2021

Characteristics relating to ovarian cancer risk: collaborative analysis of seven U.S. case-control studies. Epithelial ovarian cancer in black women. Collaborative Ovarian Cancer Group

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970226-6

7 January 2021

Peritoneal serous papillary carcinoma, a phenotypic variant of familial ovarian cancer: implications for ovarian cancer screening

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970226-6

7 January 2021

Hereditary nonpolyposis colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970226-6

7 January 2021

Preoperative serum CA-125 levels in patients with surgical stage I invasive ovarian adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970226-6

7 January 2021

A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970226-6

7 January 2021

Reproductive, genetic, and dietary risk factors for ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970226-6

7 January 2021

Oral contraceptives and the risk of hereditary ovarian cancer. Hereditary Ovarian Cancer Clinical Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970226-6

7 January 2021

Preoperative abdominopelvic computed tomographic prediction of optimal cytoreduction in epithelial ovarian carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970226-6

7 January 2021

Primary peritoneal carcinoma after prophylactic oophorectomy in women with a family history of ovarian cancer. A report of the Gilda Radner Familial Ovarian Cancer Registry.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970226-6

7 January 2021

Familial ovarian cancer: a population-based case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970226-6

7 January 2021

Risk factor for ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970226-6

7 January 2021

Early detection and screening for ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970226-6

7 January 2021

The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970226-6

7 January 2021

Clinical value of a new serum tumor marker, CA125II, in gynecologic disease: comparison with CA125

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970226-6

7 January 2021

The reduction in risk of ovarian cancer associated with oral-contraceptive use

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970226-6

7 January 2021

Intra-abdominal carcinomatosis after prophylactic oophorectomy in ovarian-cancer-prone families

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970226-6

7 January 2021

Ovarian cancer screening

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970226-6

7 January 2021

Identification of the breast cancer susceptibility gene BRCA2

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970226-6

7 January 2021

Lysophosphatidic acid as a potential biomarker for ovarian and other gynecologic cancers

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970226-6

7 January 2021

Ovarian cancer. Age contrasts in incidence, histology, disease stage at diagnosis, and mortality.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970226-6

7 January 2021

10.1016/S0889-8545(05)70226-6

Identifiers

DOI

1 reference

2 August 2017

1 reference